Kailera Therapeutics Inc. (KLRA) Live Share Price, Invest From India

Kailera Therapeutics Inc. Stock Performance

as on July 31, 2026 at 2:16 pm IST

Day's Low
Day's High
$16.50
Day's Price Range
$17.26
$17.05
3.23%
Downside
1.23%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$17.05
100.00%
Downside
-100.00%
Upside

Kailera Therapeutics Inc. share price movements today

Previous Close: $16.88
Open: $16.80
Volume: 521.3K
Day's Low - High: $16.50 - $17.26

Kailera Therapeutics Inc. Historical Returns

1 Month Return: -18.92 %
3 Month Return: -32.88 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Kailera Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Kailera Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.2B

EPS (TTM)

-3.9714

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-36.90%

Kailera Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kailera Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kailera Therapeutics Inc.	NA	$2.2B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.1B	531.7%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$124.5B	139.77%	28.41	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$72.9B	21.02%	16.29	29.65%	0.54%

Indian Investors' Interest in Kailera Therapeutics Inc. Stock

Search interest for Kailera Therapeutics Inc. Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 1, 2026 to July 31, 2026

Change:-24% versus previous 30 day period

Kailera Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Mar 2026
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-20	-84
EBITDA	-	-84
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-17	-78
Income Tax Expense	-	-
Net Income	-17	-78
Net Profit Margin	0.00%	0.00%

Kailera Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2025
Total Revenue	-
Gross Profit	-
Operating Income	-158
EBITDA	-158
Interest Expense	-
Depreciation	0
Income Before Tax	-148
Income Tax Expense	-
Net Income	-148
Net Profit Margin	0.00%

Kailera Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2026
Net Income	-78
Operating Cash Flow	-68
Investing Cash Flow	22
Financing Cash Flow	-2
Change in Cash	-48

Global Institutional Holdings in Kailera Therapeutics Inc.

Funds	Holdings
Tema ETFs	0.01%

Insights on Kailera Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 1 month, KLRA stock has moved down by -23.4%

About Kailera Therapeutics Inc.

Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions. The company develops clinical- and preclinical-stage therapies, with a product pipeline that includes injectable peptides, oral peptides, and oral small molecules. Key programs include KAI-9531, an injectable GLP-1/GIP receptor dual agonist; KAI-7535, an oral small molecule GLP-1 receptor agonist; and KAI-4729, an injectable GLP-1/GIP/glucagon receptor tri-agonist. Kailera Therapeutics holds exclusive rights for global development and commercialization of four metabolic disease assets outside of Greater China, with therapies delivered through oral and injectable formulations. The company was founded in 2024 and is based in Waltham, Massachusetts.

Organisation	Kailera Therapeutics Inc.
Headquarters	180 Third Avenue, Waltham, MA, United States, 02451
Industry	Biotechnology
CEO	Mr. Ronald C. Renaud Jr., M.B.A.
E-voting on shares	Click here to vote

Key Management of Kailera Therapeutics Inc.

Name	Title
Mr. Ronald C. Renaud Jr., M.B.A.	President, CEO & Director
Mr. Paul Douglas Burgess J.D., M.S.	Chief Operating & Business Officer
Ms. Jamie Beth Coleman	Chief Commercial Officer
Mr. Douglas W. Pagan M.B.A.	Chief Financial Officer
Maura Gavaghan	Vice President of Corporate Communications & Investor Relations
Dr. Scott M. Wasserman M.D.	Chief Medical Officer
Ms. Kathleen Tregoning M.A.	Chief Corporate Affairs Officer
Mr. Scott M. Akamine J.D.	Chief Legal Officer & Secretary
Ms. Paula A. Cloghessy SHRM-SCP, SPHR	Chief People Officer
Mr. Corey Manchester	Treasurer

FAQs

What is Kailera Therapeutics Inc. share price today?

Kailera Therapeutics Inc. share price today is $17.05 as on July 31, 2026 at 8:46 am IST at the close of the market. Kailera Therapeutics Inc. share today touched a day high of $17.26 and a low of $16.50.

What is the 52 week high and 52 week low for Kailera Therapeutics Inc. share?

Kailera Therapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Kailera Therapeutics Inc. stock price today i.e. July 31, 2026 at 8:46 am IST is closed at $17.05,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Kailera Therapeutics Inc.'s market capitalisation today?

Kailera Therapeutics Inc. market capitalisation is $0.00T as on July 31, 2026 at 8:46 am IST.

How to invest in Kailera Therapeutics Inc. Stock (KLRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kailera Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kailera Therapeutics Inc. Shares that will get you 0.0880 shares as per Kailera Therapeutics Inc. share price of $17.05 per share as on July 31, 2026 at 8:46 am IST.

What is the minimum amount required to buy Kailera Therapeutics Inc. Stock (KLRA) from India?

Indian investors can start investing in Kailera Therapeutics Inc. (KLRA) shares with as little as ₹95.68 or $1 (as of July 31, 2026 at 8:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.80 in Kailera Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 31, 2026 at 8:47 am IST). Based on Kailera Therapeutics Inc. share’s latest price of $17.05 as on July 31, 2026 at 8:46 am IST, you will get 0.5865 shares of Kailera Therapeutics Inc.. Learn more about fractional shares .